BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9261282)

  • 1. Sex differences in visceral fat lipolysis and metabolic complications of obesity.
    Lönnqvist F; Thörne A; Large V; Arner P
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1472-80. PubMed ID: 9261282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
    Lönnqvist F; Thöme A; Nilsell K; Hoffstedt J; Arner P
    J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome is related to beta 3-adrenoceptor sensitivity in visceral adipose tissue.
    Hoffstedt J; Wahrenberg H; Thörne A; Lönnqvist F
    Diabetologia; 1996 Jul; 39(7):838-44. PubMed ID: 8817109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in lipolysis between human subcutaneous and omental adipose tissues.
    Arner P
    Ann Med; 1995 Aug; 27(4):435-8. PubMed ID: 8519504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men.
    Hoffstedt J; Arner P; Hellers G; Lönnqvist F
    J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome.
    Langin D
    Pharmacol Res; 2006 Jun; 53(6):482-91. PubMed ID: 16644234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
    Hellström L; Langin D; Reynisdottir S; Dauzats M; Arner P
    Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
    Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P
    Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
    Hellström L; Rössner S; Hagström-Toft E; Reynisdottir S
    Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired insulin-mediated antilipolysis and lactate release in adipose tissue of upper-body obese women.
    Nellemann B; Gormsen LC; Sørensen LP; Christiansen JS; Nielsen S
    Obesity (Silver Spring); 2012 Jan; 20(1):57-64. PubMed ID: 21959346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased lipolysis in adipose tissues is associated with elevation of systemic free fatty acids and insulin resistance in perilipin null mice.
    Zhai W; Xu C; Ling Y; Liu S; Deng J; Qi Y; Londos C; Xu G
    Horm Metab Res; 2010 Apr; 42(4):247-53. PubMed ID: 20091459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot- and gender-related differences in the lipolytic pathway of adipose tissue from severely obese patients.
    Ramis JM; Salinas R; García-Sanz JM; Moreiro J; Proenza AM; Lladó I
    Cell Physiol Biochem; 2006; 17(3-4):173-80. PubMed ID: 16543734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of mono- and diacylglycerols in subcutaneous adipose tissue of obese and normal-weight subjects.
    Arner P; Liljeqvist L; Ostman J
    Acta Med Scand; 1976; 200(3):187-94. PubMed ID: 184690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes.
    Zhang T; He J; Xu C; Zu L; Jiang H; Pu S; Guo X; Xu G
    J Mol Endocrinol; 2009 Jan; 42(1):57-66. PubMed ID: 18955435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free fatty acid metabolism and obesity in man: in vivo in vitro comparisons.
    Lillioja S; Foley J; Bogardus C; Mott D; Howard BV
    Metabolism; 1986 Jun; 35(6):505-14. PubMed ID: 3713512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial triglyceride response in visceral obesity in men.
    Couillard C; Bergeron N; Prud'homme D; Bergeron J; Tremblay A; Bouchard C; Mauriège P; Després JP
    Diabetes; 1998 Jun; 47(6):953-60. PubMed ID: 9604874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral fat cell lipolysis and cardiovascular risk factors in obesity.
    Andersson DP; Löfgren P; Thorell A; Arner P; Hoffstedt J
    Horm Metab Res; 2011 Oct; 43(11):809-15. PubMed ID: 22009377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is visceral adiposity a significant correlate of subcutaneous adipose cell lipolysis in men?
    Mauriège P; Brochu M; Prud'homme D; Tremblay A; Nadeau A; Lemieux S; Després JP
    J Clin Endocrinol Metab; 1999 Feb; 84(2):736-42. PubMed ID: 10022446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying regional differences in lipolysis in human adipose tissue.
    Wahrenberg H; Lönnqvist F; Arner P
    J Clin Invest; 1989 Aug; 84(2):458-67. PubMed ID: 2503539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.